NCT07761364

Brief Summary

Patients admitted to intensive care units are exposed to multiple environmental and clinical factors that may affect their physiological responses. This randomized controlled trial aims to evaluate the effect of physical contact with the primary caregiver on physiological parameters in adult patients hospitalized in an intensive care unit.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Aug 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
Aug 2026Aug 2026

First Submitted

Initial submission to the registry

July 2, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 12, 2026

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

August 12, 2026

Status Verified

August 1, 2026

Enrollment Period

1 month

First QC Date

July 2, 2026

Last Update Submit

August 10, 2026

Conditions

Keywords

Intensive Care UnitCritical IllnessCritically Ill PatientsPrimary CaregiverFamily CaregiveTherapeutic TouchPhysical ContactHuman TouchPhysiological ParametersPhysiological ResponseHeart RateBlood PressureRespiratory RateOxygen SaturationCritical Care NursingPatient-Centered Care

Outcome Measures

Primary Outcomes (1)

  • Change in Heart Rate

    Heart rate, expressed as beats per minute (bpm), measured using a bedside multiparameter monitor through cutaneous electrodes. Changes in heart rate will be assessed before, during, and after the intervention.

    10 minutes before the intervention, during the intervention (10 minutes after the start of the visit), and 10 minutes after the intervention.

Secondary Outcomes (5)

  • Change in Systolic Blood Pressure

    10 minutes before the caregiver visit, during the visit (10 minutes after the start of the caregiver visit), 10 minutes after completion of the caregiver visit.

  • Change in Diastolic Blood Pressure

    10 minutes before the caregiver visit, during the visit (10 minutes after the start of the caregiver visit), 10 minutes after completion of the caregiver visit.

  • Change in Respiratory Rate

    10 minutes before the caregiver visit, during the visit (10 minutes after the start of the caregiver visit), 10 minutes after completion of the caregiver visit.

  • Change in Oxygen Saturation

    10 minutes before the caregiver visit, during the visit (10 minutes after the start of the caregiver visit), 10 minutes after completion of the caregiver visit.

  • Change in Body Temperature

    10 minutes before the caregiver visit, during the visit (10 minutes after the start of the caregiver visit), 10 minutes after completion of the caregiver visit.

Study Arms (2)

Intervention

EXPERIMENTAL

Therapeutic physical contact provided by their primary caregiver

Other: Standardized therapeutic physical contact

Standard Care Without Therapeutic Contact

NO INTERVENTION

Standard intensive care unit care without the standardized therapeutic physical contact intervention provided by the primary caregiver.

Interventions

During the pre-visit phase (30 minutes), caregivers will receive information about the study, patient's condition, infection control procedures, and training on the standardized contact protocol. During the visit phase (20 min), the caregiver will greet the patient in a customary manner (1 min); provide a gentle massage to the dorsal surface of the hand while discussing positive events of the day (6 min); gently touch the patient's forehead with the fingertips while recalling pleasant memories (3 min); gently massage the patient's cheek using the fingertips while providing encouraging and positive messages (3 minutes); massage the palm of the patient's hand using circular movements while discussing goals to be achieved after hospital discharge (4 min); and holding the patient's hand and expressing wishes for recovery and discharge (3 min). Following the visit, caregivers will be given the opportunity to share observations, comments, and feedback regarding the intervention experience.

Also known as: Physical contact
Intervention

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patient Criteria:
  • Adults aged 18 years or older.
  • Admission to the intensive care unit (ICU) for 24 to 48 hours.
  • Richmond Agitation-Sedation Scale (RASS) score between -3 and -1 or between 0 and +3.
  • Glasgow Coma Scale score greater than 13.
  • Primary Caregiver Criteria:
  • Identified as the patient's primary caregiver.
  • Willing and able to participate in the study.
  • Provides written informed consent prior to study participation.

You may not qualify if:

  • Patient Criteria:
  • Diagnosis of a neurological disorder (e.g., cerebrovascular disease or stroke).
  • Multiple organ dysfunction syndrome (MODS).
  • Unstable or difficult-to-control cardiac arrhythmias.
  • Fever (body temperature ≥ 37.5°C) at the time of assessment.
  • Hypertension (blood pressure ≥ 130/80 mmHg) at the time of assessment.
  • Primary Caregiver Criteria:
  • \- Unable to be present to perform the intervention according to the study protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Investigación del Instituto Nacional de Enfermedades Respiratorias

Mexico City, Mexico City, 14080, Mexico

RECRUITING

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Isabel Álvarez-Solorza, RN, PhD

    Universidad Autonoma del Estado de Mexico

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Isabel Álvarez-Solorza, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor-Researcher

Study Record Dates

First Submitted

July 2, 2026

First Posted

August 12, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

August 12, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) may be made available upon reasonable request to the principal investigator, subject to approval by the research team and ethics committee and in accordance with applicable regulation

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Beginning after publication of the primary study results with no predetermined end date.
Access Criteria
De-identified individual participant data (IPD) and supporting documents will be available upon reasonable request to the principal investigator. Access will be granted to researchers with a methodologically sound research proposal following review and approval by the research team and in accordance with ethical and institutional requirements. Data will be shared in a secure manner and only for approved research purposes.

Locations